Circovirus

It’s one of the most devastating and economically damaging pig diseases in the world: Porcine circovirus associated disease (PCVAD). It can strike early or appear in a late form. And once it strikes, the consequences are never good.

 Circovirus

BOEHRINGER INGELHEIM 2008 PCVAD RESEARCH AWARD

  • 10 minutes

Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces the recipients of its annual research award program directed at porcine circovirus associated disease (PCVAD). The $75,000 PCVAD Research Awards will fund three research studies designed to improve the industry’s understanding and management of this devastating disease.

 Circovirus

EUROPEAN PCV2 RESEARCH AWARDS

  • 5 minutes

EU - The EU PCVD Consortium announced awards for Professor Hans Nauwynck and Professor Joaquim Segalés in its June 2008 newsletter.

 Circovirus

FIRST EVER EUROPEAN PCV2-RESEARCH AWARD WINNERS HONOURED

  • 10 minutes

GERMANY - Prof. Hans Nauwynck, Prof. Joaquim Segalés, Danja Wiederkehr together and Dr. Xaver Sidler are the first ever winners of the European PCV2 Research Award

 Circovirus

CIRCOVIRUS VACCINE RECEIVES FOUR-MONTH DURATION OF IMMUNITY APPROVAL

  • 5 minutes

US - Boehringer Ingelheim Vetmedica, Inc., (BIVI) has announced that the U.S. Animal and Plant Health Inspection Service has approved a duration of immunity (DOI) claim for Ingelvac® CircoFLEX™ of at least four months for porcine circovirus type 2 (PCV2), the primary pathogen for porcine circovirus associated disease (PCVAD).

It can be of your interest
MASTITIS – FEED BACK INHIBITOR OF LACTATION (FIL)
Others

MASTITIS – FEED BACK INHIBITOR OF LACTATION (FIL)

  • 5 minutes

Inflammation of specific udder segments can occur at any stage during the lactation.

When milk-release is impaired by mastitis in one or more udder segments, there is the threat that FIL (a protein) will be released: when the concentration of this protein in the udder milk in creases, milk production is suppressed and eventually milk flow will stop.